116 related articles for article (PubMed ID: 18006469)
1. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury.
McGaffin KR; Sun CK; Rager JJ; Romano LC; Zou B; Mathier MA; O'Doherty RM; McTiernan CF; O'Donnell CP
Cardiovasc Res; 2008 Jan; 77(1):54-63. PubMed ID: 18006469
[TBL] [Abstract][Full Text] [Related]
2. Restoration of glucose metabolism in leptin-resistant mouse hearts after acute myocardial infarction through the activation of survival kinase pathways.
Witham W; Yester K; O'Donnell CP; McGaffin KR
J Mol Cell Cardiol; 2012 Jul; 53(1):91-100. PubMed ID: 22507542
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling.
Echtermeyer F; Harendza T; Hubrich S; Lorenz A; Herzog C; Mueller M; Schmitz M; Grund A; Larmann J; Stypmann J; Schieffer B; Lichtinghagen R; Hilfiker-Kleiner D; Wollert KC; Heineke J; Theilmeier G
Cardiovasc Res; 2011 Oct; 92(1):123-31. PubMed ID: 21632883
[TBL] [Abstract][Full Text] [Related]
4. Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.
McGaffin KR; Witham WG; Yester KA; Romano LC; O'Doherty RM; McTiernan CF; O'Donnell CP
Cardiovasc Res; 2011 Jan; 89(1):60-71. PubMed ID: 20833647
[TBL] [Abstract][Full Text] [Related]
5. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
6. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.
Barouch LA; Berkowitz DE; Harrison RW; O'Donnell CP; Hare JM
Circulation; 2003 Aug; 108(6):754-9. PubMed ID: 12885755
[TBL] [Abstract][Full Text] [Related]
7. Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.
Bodary PF; Shen Y; Ohman M; Bahrou KL; Vargas FB; Cudney SS; Wickenheiser KJ; Myers MG; Eitzman DT
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):70-6. PubMed ID: 17095713
[TBL] [Abstract][Full Text] [Related]
8. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
Amigoni M; Meris A; Thune JJ; Mangalat D; Skali H; Bourgoun M; Warnica JW; Barvik S; Arnold JM; Velazquez EJ; Van de Werf F; Ghali J; McMurray JJ; Køber L; Pfeffer MA; Solomon SD
Eur Heart J; 2007 Feb; 28(3):326-33. PubMed ID: 17251259
[TBL] [Abstract][Full Text] [Related]
9. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
10. LRb signals act within a distributed network of leptin-responsive neurones to mediate leptin action.
Leinninger GM; Myers MG
Acta Physiol (Oxf); 2008 Jan; 192(1):49-59. PubMed ID: 18171429
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction.
Ikeuchi M; Matsusaka H; Kang D; Matsushima S; Ide T; Kubota T; Fujiwara T; Hamasaki N; Takeshita A; Sunagawa K; Tsutsui H
Circulation; 2005 Aug; 112(5):683-90. PubMed ID: 16043643
[TBL] [Abstract][Full Text] [Related]
13. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
Makino T; Hattori Y; Matsuda N; Onozuka H; Sakuma I; Kitabatake A
J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
16. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
17. Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.
Tan Z; Dai T; Zhong X; Tian Y; Leppo MK; Gao WD
Eur J Pharmacol; 2009 Oct; 621(1-3):71-7. PubMed ID: 19737552
[TBL] [Abstract][Full Text] [Related]
18. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction.
Hoefer J; Azam MA; Kroetsch JT; Leong-Poi H; Momen MA; Voigtlaender-Bolz J; Scherer EQ; Meissner A; Bolz SS; Husain M
Circ Res; 2010 Oct; 107(7):923-33. PubMed ID: 20671234
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of leptin receptor in high- and low-fat-fed Osborne-Mendel and S5B/Pl rats.
Madiehe AM; Schaffhauser AO; Braymer DH; Bray GA; York DA
Obes Res; 2000 Sep; 8(6):467-74. PubMed ID: 11011914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
